506525 Stock Overview
Kanoria Chemicals & Industries Limited manufactures and sells chemical intermediates in India.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Kanoria Chemicals & Industries Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹126.75 |
52 Week High | ₹156.30 |
52 Week Low | ₹100.25 |
Beta | 0.48 |
1 Month Change | 15.65% |
3 Month Change | -7.38% |
1 Year Change | 3.94% |
3 Year Change | 9.17% |
5 Year Change | 110.37% |
Change since IPO | 1,146.73% |
Recent News & Updates
Recent updates
Shareholder Returns
506525 | IN Chemicals | IN Market | |
---|---|---|---|
7D | 0.7% | -1.1% | -1.5% |
1Y | 3.9% | 16.9% | 45.0% |
Return vs Industry: 506525 underperformed the Indian Chemicals industry which returned 16.9% over the past year.
Return vs Market: 506525 underperformed the Indian Market which returned 45% over the past year.
Price Volatility
506525 volatility | |
---|---|
506525 Average Weekly Movement | 6.0% |
Chemicals Industry Average Movement | 6.4% |
Market Average Movement | 6.9% |
10% most volatile stocks in IN Market | 10.1% |
10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 506525 has not had significant price volatility in the past 3 months.
Volatility Over Time: 506525's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1960 | 442 | Rajya Kanoria | www.kanoriachem.com |
Kanoria Chemicals & Industries Limited manufactures and sells chemical intermediates in India. The company operates through Alco Chemicals and Solar Power segments. It provides chemicals, such as acetaldehyde, di-pentaerythritol, formaldehyde, hexamine, pentaerythritol, phenolic resins, and sodium formate.
Kanoria Chemicals & Industries Limited Fundamentals Summary
506525 fundamental statistics | |
---|---|
Market cap | ₹5.50b |
Earnings (TTM) | -₹306.56m |
Revenue (TTM) | ₹15.60b |
0.4x
P/S Ratio-17.9x
P/E RatioIs 506525 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
506525 income statement (TTM) | |
---|---|
Revenue | ₹15.60b |
Cost of Revenue | ₹11.04b |
Gross Profit | ₹4.55b |
Other Expenses | ₹4.86b |
Earnings | -₹306.56m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 30, 2024
Earnings per share (EPS) | -7.02 |
Gross Margin | 29.20% |
Net Profit Margin | -1.97% |
Debt/Equity Ratio | 75.1% |
How did 506525 perform over the long term?
See historical performance and comparison